Accumulating evidence has shown that abnormal cleavage of APP is a central process in the pathological mechanisms of Alzheimer’s disease (AD) (27–29), and the Wnt/β-catenin pathway is dysfunctional in AD brains (30–32). This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.